An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02087748|
Recruitment Status : Completed
First Posted : March 14, 2014
Results First Posted : December 10, 2014
Last Update Posted : December 10, 2014
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Triple (Participant, Care Provider, Investigator); Primary Purpose: Treatment|
Delayed Onset Muscle Soreness
Drug: 1% diclofenac sodium gel
Dates of recruitment period: First subject was enrolled in March 2014 and the last subject was enrolled in April 2014.
Types of location: Investigative site was located at one research center.
|Arm/Group Title||1% Diclofenac Sodium Gel|
|Arm/Group Description||Diclofenac sodium 1% gel 4 grams applied topically Q6 hours for 48 hours to one leg, and placebo to the other leg.|
|Period Title: Overall Study|